Evidence map›Paper›PMID 29440179›Full record

ArticleDrug metabolism and disposition: the biological fate of chemicals2018

Role of c-Jun-N-Terminal Kinase in Pregnane X Receptor-Mediated Induction of Human Cytochrome P4503A4 In Vitro.

Guncha Taneja, Chun Chu, Paramahamsa Maturu, Bhagavatula Moorthy, Romi Ghose

Open access · bronzeAbstract read
In one paragraph

Article in Drug metabolism and disposition: the biological fate of chemicals, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
2.3field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 18 citations in OpenAlex.

  1. Review
  2. Review
  3. Down-Regulation of CYP3A4 by the KInternational journal of molecular sciences · 2023
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Opportunities in Novel Psychotropic Drug Design from Natural Compounds.The international journal of neuropsychopharmacology · 2019
    Review
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Guncha TanejaDepartment of Pharmacological and Pharmaceutical Sciences, College of Pharmacy, University of Houston (G.T., R.G.), and Department of Pediatrics, Baylor College of Medicine (C.C., P.M., B.M.), Houston, Texas.
Chun ChuDepartment of Pharmacological and Pharmaceutical Sciences, College of Pharmacy, University of Houston (G.T., R.G.), and Department of Pediatrics, Baylor College of Medicine (C.C., P.M., B.M.), Houston, Texas.
Paramahamsa MaturuDepartment of Pharmacological and Pharmaceutical Sciences, College of Pharmacy, University of Houston (G.T., R.G.), and Department of Pediatrics, Baylor College of Medicine (C.C., P.M., B.M.), Houston, Texas.
Bhagavatula MoorthyDepartment of Pharmacological and Pharmaceutical Sciences, College of Pharmacy, University of Houston (G.T., R.G.), and Department of Pediatrics, Baylor College of Medicine (C.C., P.M., B.M.), Houston, Texas rghose@central.uh.edu bmoorthy@bcm.tmc.edu.
Romi GhoseDepartment of Pharmacological and Pharmaceutical Sciences, College of Pharmacy, University of Houston (G.T., R.G.), and Department of Pediatrics, Baylor College of Medicine (C.C., P.M., B.M.), Houston, Texas rghose@central.uh.edu bmoorthy@bcm.tmc.edu.
Baylor College of Medicine · USUniversity of Houston · US

Funding

Functional roles of Nrf2 and NQO1 genetic variants in hyperoxic lung injury-ARDSR01HL112516 · NHLBI · BAYLOR COLLEGE OF MEDICINE · PI MOORTHY, BHAGAVATULA · 2012 to 2016
$2.9M
Supplement2: Mechanistic Roles of Cytochrome P4501A Enzymes in Hyperoxic Lung InjuryR01HL129794 · NHLBI · BAYLOR COLLEGE OF MEDICINE · PI MOORTHY, BHAGAVATULA · 2016 to 2019
$2.2M
Role of cytochrome P4501B1 in oxygen-mediated pulmonary injuryR01ES019689 · NIEHS · BAYLOR COLLEGE OF MEDICINE · PI MOORTHY, BHAGAVATULA · 2011 to 2015
$2.1M
Novel in vivo regulatory mechanisms of human CYP3A4R21DA035751 · NIDA · UNIVERSITY OF HOUSTON · PI GHOSE, ROMI, MOORTHY, BHAGAVATULA · 2014 to 2015
$428k
NHLBI NIH HHS R01 HL112516NHLBI NIH HHS R01 HL129794NIDA NIH HHS R21 DA035751NIEHS NIH HHS R01 ES019689
6 · The paper itself

Abstract

Cytochrome P450 CYP3A4 is the most abundant drug-metabolizing enzyme and is responsible for the metabolism of ∼50% of clinically available drugs. Induction of CYP3A4 impacts the disposition of its substrates and leads to harmful clinical consequences, such as failure of therapy. To prevent such undesirable consequences, the molecular mechanisms of regulation of CYP3A4 need to be fully understood.

Indexed as

Cell Line, TumorCytochrome P-450 CYP3AEnzyme InductionHep G2 CellsHumansInactivation, MetabolicJNK Mitogen-Activated Protein KinasesLiverPregnane X ReceptorPromoter Regions, GeneticReceptors, SteroidRifampinRNA, Small InterferingCYP3A4 protein, humanCytochrome P-450 CYP3AJNK Mitogen-Activated Protein KinasesPregnane X ReceptorReceptors, SteroidRifampinRNA, Small Interfering

Identifiers

PMID29440179
PMCPMC5829542
OpenAlexW2794107488

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.